Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,000	414 Pages	GlobalData	October, 2020	GBDT16421232

Best Price Guarantee
Price	from $4,000
Length	414 Pages
Publisher	GlobalData
Published Date	October, 2020
SKU	GBDT16421232

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, “Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 provides comprehensive information about the Breast Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Breast Cancer Diagnostic Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

Introduction
- Breast Cancer Overview
Products under Development
- Breast Cancer - Pipeline Products by Stage of Development
  - Table Figure 1: Breast Cancer - Pipeline Products by Stage of Development
  - Table Breast Cancer - Pipeline Products by Stage of Development
- Breast Cancer - Pipeline Products by Territory
  - Table Figure 2: Breast Cancer - Pipeline Products by Territory
  - Table Breast Cancer - Pipeline Products by Territory
- Breast Cancer - Pipeline Products by Regulatory Path
  - Table Figure 3: Breast Cancer - Pipeline Products by Regulatory Path
  - Table Breast Cancer - Pipeline Products by Regulatory Path
- Breast Cancer - Ongoing Clinical Trials
  - Table Figure 4: Breast Cancer - Ongoing Clinical Trials
  - Table Breast Cancer - Ongoing Clinical Trials
- Breast C-ancer - Pipeline Products by Estimated Approval Date
  - Table Figure 5: Breast Cancer - Pipeline Products by Estimated Approval Date
  - Table Breast Cancer - Pipeline Products by Estimated Approval Date
Breast Cancer - Pipeline Products under Development by Companies
- Breast Cancer Companies - Pipeline Products by Stage of Development
  - Table Breast Cancer Companies - Pipeline Products by Stage of Development
- Breast Cancer - Companies Pipeline Products by Stage of Development
  - Table Breast Cancer - Companies Pipeline Products by Stage of Development
Breast Cancer Companies and Product Overview
- A&G Pharmaceutical Inc Company Overview
  - A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Onco 88 - Breast Cancer - Product Status
    - Table Onco 88 - Breast Cancer - Product Description
    - Table OncoStain 88 - Breast Cancer - Product Status
    - Table OncoStain 88 - Breast Cancer - Product Description
- Abviva Inc (Inactive) Company Overview
  - Abviva Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Abviva Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Mammastatin Serum Assay - Product Status
    - Table Mammastatin Serum Assay - Product Description
- Accelerated Medical Diagnostics LLC Company Overview
  - Accelerated Medical Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Accelerated Medical Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Test - Oxaliplatin - Product Status
    - Table Companion Diagnostic Test - Oxaliplatin - Product Description
- Acobiom Company Overview
  - Acobiom Pipeline Products & Ongoing Clinical Trials Overview
    - Table Acobiom Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Test - Breast Cancer - Product Status(Acobiom)
    - Table Companion Diagnostic Test - Breast Cancer - Product Description(Acobiom)
    - Table Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status
    - Table Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description
    - Table Diagnostic/Prognostic Assay - Breast Cancer - Product Status
    - Table Diagnostic/Prognostic Assay - Breast Cancer - Product Description
- Affichem SA Company Overview
  - Affichem SA Pipeline Products & Ongoing Clinical Trials Overview
    - Table Affichem SA Pipeline Products & Ongoing Clinical Trials Overview
    - Table AF300 Based Chromatographic Kit - Product Status
    - Table AF300 Based Chromatographic Kit - Product Description
    - Table AF300 Based Enzymatic Immunoassay Kit - Product Status
    - Table AF300 Based Enzymatic Immunoassay Kit - Product Description
- AIT Austrian Institute of Technology GmbH Company Overview
  - AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
    - Table AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status(AIT Austrian Institute of Technology GmbH)
    - Table Diagnostic Assay - Breast Cancer - Product Description(AIT Austrian Institute of Technology GmbH)
- Albert Ludwigs University of Freiburg Company Overview
  - Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
    - Table Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
    - Table mRNA Based Diagnostic Assay - Breast Cancer - Product Status
    - Table mRNA Based Diagnostic Assay - Breast Cancer - Product Description
- Alere Inc Company Overview
  - Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table NMP66 Test - Product Status
    - Table NMP66 Test - Product Description
- Allarity Therapeutics A/S Company Overview
  - Allarity Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
    - Table Allarity Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
    - Table Epirubicin DRP Assay - Product Status
    - Table Epirubicin DRP Assay - Product Description
- Almac Diagnostic Services Ltd Company Overview
  - Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table DNA Damage Response Deficiency Assay - Breast Cancer - Product Status
    - Table DNA Damage Response Deficiency Assay - Breast Cancer - Product Description
- Amarantus Bioscience Holdings Inc Company Overview
  - Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table NuroPro - Breast Cancer - Product Status
    - Table NuroPro - Breast Cancer - Product Description
- AngioGenex Inc Company Overview
  - AngioGenex Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table AngioGenex Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Status
    - Table Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Description
- Anixa Diagnostics Corporation Company Overview
  - Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
    - Table Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
    - Table Cchek - Breast Cancer - Product Status
    - Table Cchek - Breast Cancer - Product Description
    - Table Cchek - Breast Cancer Confirmatory Test - Product Status
    - Table Cchek - Breast Cancer Confirmatory Test - Product Description
    - Table Cchek - Breast Cancer Recurrence Test - Product Status
    - Table Cchek - Breast Cancer Recurrence Test - Product Description
    - Table Cchek - Breast Cancer Treatment Monitoring Test - Product Status
    - Table Cchek - Breast Cancer Treatment Monitoring Test - Product Description
    - Table Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview
    - Table Cchek - Breast Cancer - Combining the Immunophenotyping of MDSCs and Lymphocytes with Artificial Intelligence (AI) to Predict Early Stage Breast Cancer
    - Table Cchek - Breast Cancer - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors
- Armune BioScience Inc Company Overview
  - Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(Armune BioScience Inc)
    - Table Diagnostic Test - Breast Cancer - Product Description(Armune BioScience Inc)
- Arno Therapeutics Inc Company Overview
  - Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Activated Estrogen Receptor Biomarker Assay - Product Status
    - Table Activated Estrogen Receptor Biomarker Assay - Product Description
    - Table Onapristone Companion Diagnostic Assay - Breast Cancer - Product Status
    - Table Onapristone Companion Diagnostic Assay - Breast Cancer - Product Description
- Assurance Biosciences, Inc. (Inactive) Company Overview
  - Assurance Biosciences, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Assurance Biosciences, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Salivary-Based Assay - Breast Cancer - Product Status
    - Table Salivary-Based Assay - Breast Cancer - Product Description
- Atossa Therapeutics Inc Company Overview
  - Atossa Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Atossa Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table ArgusCYTE Breast Health Test - Product Status
    - Table ArgusCYTE Breast Health Test - Product Description
    - Table Companion Diagnostic Test - Breast Cancer - Product Status(Atossa Therapeutics Inc)
    - Table Companion Diagnostic Test - Breast Cancer - Product Description(Atossa Therapeutics Inc)
    - Table Companion Diagnostic Test - PED - Product Status
    - Table Companion Diagnostic Test - PED - Product Description
    - Table Next Generation MASCT System - Product Status
    - Table Next Generation MASCT System - Product Description
    - Table NextCYTE Breast Cancer Test - Product Status
    - Table NextCYTE Breast Cancer Test - Product Description
- Aurelium BioPharma Inc. Company Overview
  - Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Cancer Screening Test - Product Status
    - Table Breast Cancer Screening Test - Product Description
    - Table MMD ELISA Test - Breast Cancer - Product Status
    - Table MMD ELISA Test - Breast Cancer - Product Description
- Autoimmune Technologies LLC Company Overview
  - Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status
    - Table Diagnostic Assay - Breast Cancer - Product Description
- Avant Diagnostics Inc Company Overview
  - Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Status
    - Table Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Description
- Ayanda Biosystems SA (Inactive) Company Overview
  - Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status
    - Table Diagnostic Test - Breast Cancer - Product Description
- BARD1 Life Sciences Ltd Company Overview
  - BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table BARD1 Breast Cancer Test - Product Status
    - Table BARD1 Breast Cancer Test - Product Description
    - Table SubB2M ELISA Assay - Product Status
    - Table SubB2M ELISA Assay - Product Description
- Baylor College of Medicine Company Overview
  - Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
    - Table Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
    - Table Mitochondria-Regulated Cancer Signature - Breast Cancer - Product Status
    - Table Mitochondria-Regulated Cancer Signature - Breast Cancer - Product Description
- BCAL Diagnostics Pty Limited Company Overview
  - BCAL Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
    - Table BCAL Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
    - Table BCAL Test - Breast Cancer - Product Status
    - Table BCAL Test - Breast Cancer - Product Description
- Becton Dickinson and Co Company Overview
  - Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
    - Table Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(Becton Dickinson and Co)
    - Table Diagnostic Test - Breast Cancer - Product Description(Becton Dickinson and Co)
- Biocrates Life Sciences AG Company Overview
  - Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
    - Table Metabolomic Biomarker Assay - Breast Cancer - Product Status
    - Table Metabolomic Biomarker Assay - Breast Cancer - Product Description
- BioDesign Institute at Arizona State University Company Overview
  - BioDesign Institute at Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
    - Table BioDesign Institute at Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Test - Basal-Like Breast Cancer - Product Status
    - Table Biomarker Test - Basal-Like Breast Cancer - Product Description
- Biodesix Inc Company Overview
  - Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table VeriStrat - Breast Cancer - Product Status
    - Table VeriStrat - Breast Cancer - Product Description
- BioGenex Laboratories Inc Company Overview
  - BioGenex Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table BioGenex Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table IHC System - Breast Cancer - Product Status
    - Table IHC System - Breast Cancer - Product Description
- Biolidics Ltd Company Overview
  - Biolidics Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biolidics Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Liquid Biopsy Test - Breast Cancer Recurrence - Product Status
    - Table Liquid Biopsy Test - Breast Cancer Recurrence - Product Description
- BioMarCare Technologies Ltd Company Overview
  - BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast PARpanel Biopsy - Product Status
    - Table Breast PARpanel Biopsy - Product Description
    - Table Breast PARpanel Blood - Product Status
    - Table Breast PARpanel Blood - Product Description
- BioMark Diagnostics Inc Company Overview
  - BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Metabolomics-based Diagnostic Assay - Breast Cancer - Product Status
    - Table Metabolomics-based Diagnostic Assay - Breast Cancer - Product Description
- BioMarker Strategies LLC Company Overview
  - BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Ex Vivo Biomarker Test - Breast Cancer - Product Status
    - Table Ex Vivo Biomarker Test - Breast Cancer - Product Description
- bioMerieux SA Company Overview
  - bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview
    - Table bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
    - Table Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
- Biomoda Inc Company Overview
  - Biomoda Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomoda Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table CyPath Diagnostic Assay - Breast Cancer - Product Status
    - Table CyPath Diagnostic Assay - Breast Cancer - Product Description
- Biosceptre International Ltd Company Overview
  - Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Cancer IHC Diagnostic Test - Product Status
    - Table Breast Cancer IHC Diagnostic Test - Product Description
- BioSystems International Company Overview
  - BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
    - Table BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(BioSystems International)
    - Table Diagnostic Test - Breast Cancer - Product Description(BioSystems International)
- Caprion Biosciences Inc Company Overview
  - Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status(Caprion Biosciences Inc)
    - Table Diagnostic Assay - Breast Cancer - Product Description(Caprion Biosciences Inc)
- Caris Life Sciences Inc Company Overview
  - Caris Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Caris Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Assay - Breast Cancer - Product Status(Caris Life Sciences Inc)
    - Table Companion Diagnostic Assay - Breast Cancer - Product Description(Caris Life Sciences Inc)
- Celcuity Inc Company Overview
  - Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table CELsignia Test - Breast Cancer - Product Status
    - Table CELsignia Test - Breast Cancer - Product Description
    - Table CELx HSF Test - Product Status
    - Table CELx HSF Test - Product Description
- Cellanyx Diagnostics, Inc. Company Overview
  - Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Cellanyx Test - Breast Cancer - Product Status
    - Table Cellanyx Test - Breast Cancer - Product Description
- CellXplore, Inc. Company Overview
  - CellXplore, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table CellXplore, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status(CellXplore, Inc.)
    - Table Diagnostic Assay - Breast Cancer - Product Description(CellXplore, Inc.)
- Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Company Overview
  - Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Pipeline Products & Ongoing Clinical Trials Overview
    - Table Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker - Early Stage Breast Cancer - Product Status
    - Table Biomarker - Early Stage Breast Cancer - Product Description
- Cepheid Inc Company Overview
  - Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table XPERT Breast CA Monitoring Test - Product Status
    - Table XPERT Breast CA Monitoring Test - Product Description
    - Table Xpert Breast CA Prognostic Signature Assay - Product Status
    - Table Xpert Breast CA Prognostic Signature Assay - Product Description
- Ceres Nanosciences Inc Company Overview
  - Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Nanotrap Breast Cancer Biomarker Test - Product Status
    - Table Nanotrap Breast Cancer Biomarker Test - Product Description
- Cernostics Inc Company Overview
  - Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table TissueCypher Breast Cancer Test - Product Status
    - Table TissueCypher Breast Cancer Test - Product Description
- China Sky One Medical Inc Company Overview
  - China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Kit - Breast Cancer - Product Status(China Sky One Medical Inc)
    - Table Diagnostic Kit - Breast Cancer - Product Description(China Sky One Medical Inc)
- Chronix Biomedical Inc Company Overview
  - Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Test - Breast Cancer - Product Status(Chronix Biomedical Inc)
    - Table Companion Diagnostic Test - Breast Cancer - Product Description(Chronix Biomedical Inc)
- City of Hope Company Overview
  - City of Hope Pipeline Products & Ongoing Clinical Trials Overview
    - Table City of Hope Pipeline Products & Ongoing Clinical Trials Overview
    - Table Blood Test - Breast Cancer - Product Status
    - Table Blood Test - Breast Cancer - Product Description
- Clarient Inc Company Overview
  - Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Mammotax - Product Status
    - Table Mammotax - Product Description
- Cleveland Diagnostics Inc. Company Overview
  - Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Blood-Based Diagnostic Test - Breast Cancer - Product Status(Cleveland Diagnostics Inc)
    - Table Blood-Based Diagnostic Test - Breast Cancer - Product Description(Cleveland Diagnostics Inc)
- CompanDX Ltd Company Overview
  - CompanDX Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table CompanDX Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Assay - Breast Cancer - Product Status(CompanDX Ltd)
    - Table Biomarker Assay - Breast Cancer - Product Description(CompanDX Ltd)
- Courtagen Life Sciences Inc Company Overview
  - Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Cancer Diagnostic Panel - Product Status
    - Table Breast Cancer Diagnostic Panel - Product Description
- Daan Gene Co Ltd Company Overview
  - Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Real Time PCR Kit - ER - Product Status
    - Table Real Time PCR Kit - ER - Product Description
- Dana-Farber Cancer Institute Inc Company Overview
  - Dana-Farber Cancer Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Dana-Farber Cancer Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Assay - Breast Cancer - Product Status(Dana-Farber Cancer Institute Inc)
    - Table Biomarker Assay - Breast Cancer - Product Description(Dana-Farber Cancer Institute Inc)
- Dartmouth College Company Overview
  - Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
    - Table Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
    - Table ISH/IHC Assay - Breast Cancer - Product Status
    - Table ISH/IHC Assay - Breast Cancer - Product Description
- Dublin City University Company Overview
  - Dublin City University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Dublin City University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Based Assay - Breast Cancer - Product Status
    - Table Biomarker Based Assay - Breast Cancer - Product Description
- Entopsis LLC Company Overview
  - Entopsis LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Entopsis LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table OpsisDx Test - Breast Cancer - Product Status
    - Table OpsisDx Test - Breast Cancer - Product Description
- Eurobio Scientific SA Company Overview
  - Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview
    - Table Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Test - Breast Cancer - Product Status
    - Table Companion Diagnostic Test - Breast Cancer - Product Description
    - Table EHT Dx 11 - Product Status
    - Table EHT Dx 11 - Product Description
    - Table EHT Dx14 - Product Status
    - Table EHT Dx14 - Product Description
- Exact Sciences Corp Company Overview
  - Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Idylla IVD Oncotype DX Breast Recurrence Score Test - Product Status
    - Table Idylla IVD Oncotype DX Breast Recurrence Score Test - Product Description
    - Table Liquid Biopsy Test - Breast Cancer - Product Status(Exact Sciences Corp)
    - Table Liquid Biopsy Test - Breast Cancer - Product Description(Exact Sciences Corp)
- Exosome Diagnostics Inc Company Overview
  - Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer Signature - Product Status
    - Table Diagnostic Assay - Breast Cancer Signature - Product Description
- Exosomics Siena SpA Company Overview
  - Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
    - Table Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
    - Table ExoTEST Breast - Product Status
    - Table ExoTEST Breast - Product Description
- Fahy Gurteen UK Ltd Company Overview
  - Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status
    - Table Diagnostic Test - Breast Cancer - Product Description
- Fina Biotech SL Company Overview
  - Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
    - Table Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
    - Table Dx Bioenergetic Signature - Breast Cancer - Product Status
    - Table Dx Bioenergetic Signature - Breast Cancer - Product Description
- Fluxion Biosciences Inc Company Overview
  - Fluxion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Fluxion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table IsoFlux CTC Liquid Biopsy System - Breast Cancer - Product Status
    - Table IsoFlux CTC Liquid Biopsy System - Breast Cancer - Product Description
- Fournira Optime Diagnostics Company Overview
  - Fournira Optime Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
    - Table Fournira Optime Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
    - Table Fournira Diagnostic Kit - Breast Cancer - Product Status
    - Table Fournira Diagnostic Kit - Breast Cancer - Product Description
- French National Institute of Health and Medical Research Company Overview
  - French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
    - Table French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status
    - Table Diagnostic Assay - Breast Cancer - Product Description
    - Table PTPL1 Based Prognostic Assay - Breast Cancer - Product Status
    - Table PTPL1 Based Prognostic Assay - Breast Cancer - Product Description
- Genome Diagnostics Pvt Ltd Company Overview
  - Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Her-2 neu Real Time PCR Kit - Product Status
    - Table Her-2 neu Real Time PCR Kit - Product Description
- GenomicTree Co Ltd Company Overview
  - GenomicTree Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table GenomicTree Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table EarlyTect Breast Cancer - Product Status
    - Table EarlyTect Breast Cancer - Product Description
- Genoptix Inc Company Overview
  - Genoptix Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Genoptix Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Estrogen Receptor Assay - Product Status
    - Table Estrogen Receptor Assay - Product Description
    - Table HER2 Receptor Assay - Product Status
    - Table HER2 Receptor Assay - Product Description
- George Washington University Company Overview
  - George Washington University Pipeline Products & Ongoing Clinical Trials Overview
    - Table George Washington University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Blood-Based miRNA Assay - Breast Cancer - Product Status
    - Table Blood-Based miRNA Assay - Breast Cancer - Product Description
- German Cancer Research Center Company Overview
  - German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
    - Table German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Metastatic Breast Cancer - Product Status
    - Table Diagnostic Assay - Metastatic Breast Cancer - Product Description
    - Table Protein Biomarker Set - ER-alpha Positive Breast Cancer - Product Status
    - Table Protein Biomarker Set - ER-alpha Positive Breast Cancer - Product Description
- Ghent University Company Overview
  - Ghent University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Ghent University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Prognostic Test - Breast Cancer - Product Status
    - Table Prognostic Test - Breast Cancer - Product Description
- GlyCa BioSciences Inc Company Overview
  - GlyCa BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table GlyCa BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Carbohydrate Biomarker - Breast Cancer - Product Status
    - Table Carbohydrate Biomarker - Breast Cancer - Product Description
- GlycoZym USA Inc Company Overview
  - GlycoZym USA Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table GlycoZym USA Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status(GlycoZym USA Inc)
    - Table Diagnostic Assay - Breast Cancer - Product Description(GlycoZym USA Inc)
- Guardant Health Inc Company Overview
  - Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Guardant360 CDx Test - Elacestrant - Product Status
    - Table Guardant360 CDx Test - Elacestrant - Product Description
    - Table Guardant Health Inc - Ongoing Clinical Trials Overview
    - Table Guardant360 CDx Test - Elacestrant - Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients with ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase III Randomized, Open-label, Active-controlled, Multi-center Trial
- H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
  - H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status(H. Lee Moffitt Cancer Center & Research Institute Inc)
    - Table Diagnostic Assay - Breast Cancer - Product Description(H. Lee Moffitt Cancer Center & Research Institute Inc)
- Hai Kang Life Corp Ltd Company Overview
  - Hai Kang Life Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Hai Kang Life Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(Hai Kang Life Corp Ltd)
    - Table Diagnostic Test - Breast Cancer - Product Description(Hai Kang Life Corp Ltd)
- Health Discovery Corp Company Overview
  - Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(Health Discovery Corp)
    - Table Diagnostic Test - Breast Cancer - Product Description(Health Discovery Corp)
- HealthTell Inc Company Overview
  - HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table ImmunoSignature Test - Breast Cancer - Product Status
    - Table ImmunoSignature Test - Breast Cancer - Product Description
- Hebrew University of Jerusalem Company Overview
  - Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
    - Table Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
    - Table Antibody Based Diagnostic Assay - Breast Cancer - Product Status
    - Table Antibody Based Diagnostic Assay - Breast Cancer - Product Description
- Heragen Inc Company Overview
  - Heragen Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Heragen Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Cancer Recurrence Test - Product Status
    - Table Breast Cancer Recurrence Test - Product Description
- Hitachi Chemical Diagnostics Inc Company Overview
  - Hitachi Chemical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Hitachi Chemical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Urine Based Diagnostic Test - Breast Cancer - Product Status
    - Table Urine Based Diagnostic Test - Breast Cancer - Product Description
- Houston Methodist Hospital Company Overview
  - Houston Methodist Hospital Pipeline Products & Ongoing Clinical Trials Overview
    - Table Houston Methodist Hospital Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Test - Breast Cancer - Product Status(Houston Methodist Hospital)
    - Table Biomarker Test - Breast Cancer - Product Description(Houston Methodist Hospital)
- Ikonisys Inc Company Overview
  - Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table oncoFISH breast - Product Status
    - Table oncoFISH breast - Product Description
- Immunovia AB Company Overview
  - Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
    - Table Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
    - Table IMMray - Breast Cancer - Product Status
    - Table IMMray - Breast Cancer - Product Description
- Inanovate Inc Company Overview
  - Inanovate Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Inanovate Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Cancer Monitoring Test - Product Status
    - Table Breast Cancer Monitoring Test - Product Description
    - Table Inanovate Inc - Ongoing Clinical Trials Overview
    - Table Breast Cancer Monitoring Test - Autoantibodies in Breast Cancer Detection
- Insight Genetics Inc Company Overview
  - Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Insight ALK ECD Assay - Product Status
    - Table Insight ALK ECD Assay - Product Description
- Inspirata Inc Company Overview
  - Inspirata Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Inspirata Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table CHIP Assay - Product Status
    - Table CHIP Assay - Product Description
- Institute of Cancer Research Company Overview
  - Institute of Cancer Research Pipeline Products & Ongoing Clinical Trials Overview
    - Table Institute of Cancer Research Pipeline Products & Ongoing Clinical Trials Overview
    - Table erbB2 Diagnostic Assay - Product Status
    - Table erbB2 Diagnostic Assay - Product Description
- Institute of Molecular and Translational Medicine Company Overview
  - Institute of Molecular and Translational Medicine Pipeline Products & Ongoing Clinical Trials Overview
    - Table Institute of Molecular and Translational Medicine Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Biomarker - Breast Cancer - Product Status
    - Table Diagnostic Biomarker - Breast Cancer - Product Description
    - Table HER2 Biomarker Kit - Breast Cancer - Product Status
    - Table HER2 Biomarker Kit - Breast Cancer - Product Description
- IPDx Immunoprofiling Diagnostics GmbH Company Overview
  - IPDx Immunoprofiling Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
    - Table IPDx Immunoprofiling Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(IPDx Immunoprofiling Diagnostics GmbH)
    - Table Diagnostic Test - Breast Cancer - Product Description(IPDx Immunoprofiling Diagnostics GmbH)
- IRIS International Inc Company Overview
  - IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table NADIA - Breast Cancer - Product Status
    - Table NADIA - Breast Cancer - Product Description
- Johns Hopkins University Company Overview
  - Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
    - Table 5hmC Marker Assay - Breast Cancer - Product Status
    - Table 5hmC Marker Assay - Breast Cancer - Product Description
    - Table Claudins Biomarker Assay - Product Status
    - Table Claudins Biomarker Assay - Product Description
    - Table MAqCI - Product Status
    - Table MAqCI - Product Description
    - Table Molecular Marker Detection Kit - Breast Cancer - Product Status
    - Table Molecular Marker Detection Kit - Breast Cancer - Product Description
- Jonakee Cancer Research, Inc. Company Overview
  - Jonakee Cancer Research, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Jonakee Cancer Research, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Kit - Breast Cancer - Product Status
    - Table Diagnostic Kit - Breast Cancer - Product Description
- Kalgene Pharmaceuticals Inc Company Overview
  - Kalgene Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Kalgene Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Assay - Breast Cancer - Product Status
    - Table Companion Diagnostic Assay - Breast Cancer - Product Description
- Leica Biosystems Nussloch GmbH Company Overview
  - Leica Biosystems Nussloch GmbH Pipeline Products & Ongoing Clinical Trials Overview
    - Table Leica Biosystems Nussloch GmbH Pipeline Products & Ongoing Clinical Trials Overview
    - Table Neuvax Companion Diagnostic Assay - Product Status
    - Table Neuvax Companion Diagnostic Assay - Product Description
- Liv Diagnostics AB Company Overview
  - Liv Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
    - Table Liv Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
    - Table CellRACE - Product Status
    - Table CellRACE - Product Description
- Louisville Bioscience Inc (Inactive) Company Overview
  - Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Cancer Remission pT Test - Product Status
    - Table Breast Cancer Remission pT Test - Product Description
- MabCure Inc Company Overview
  - MabCure Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table MabCure Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(MabCure Inc)
    - Table Diagnostic Test - Breast Cancer - Product Description(MabCure Inc)
- Matrix-Bio Inc Company Overview
  - Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table VeraMarker BCD Test - Product Status
    - Table VeraMarker BCD Test - Product Description
    - Table VeraMarker BCD-Q Test - Product Status
    - Table VeraMarker BCD-Q Test - Product Description
    - Table VeraMarker BCR Test - LDT - Product Status
    - Table VeraMarker BCR Test - LDT - Product Description
    - Table VeraMarker Breast Cancer Test - Preoperative Chemotherapy - Product Status
    - Table VeraMarker Breast Cancer Test - Preoperative Chemotherapy - Product Description
- MDNA Life Sciences Inc Company Overview
  - MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Mitomic Breast Test - Product Status
    - Table Mitomic Breast Test - Product Description
- MDxHealth SA Company Overview
  - -MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
    - Table MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
    - Table PharmacoDx - Breast Cancer - Product Status
    - Table PharmacoDx - Breast Cancer - Product Description
- MEDITE Cancer Diagnostics Inc Company Overview
  - MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Screening Assay - Breast Cancer - Product Status
    - Table Screening Assay - Breast Cancer - Product Description
- MedMira Inc Company Overview
  - MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 - Product Status
    - Table HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 - Product Description
- MedPacto Inc Company Overview
  - M-edPacto Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table MedPacto Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table MO-B2 Diagnostic Kit - Product Status
    - Table MO-B2 Diagnostic Kit - Product Description
- Metabolomic Technologies Inc Company Overview
  - Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table BreastDx - Product Status
    - Table BreastDx - Product Description
- MetaStat Inc Company Overview
  - MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table MenaCalc Breast - Product Status
    - Table MenaCalc Breast - Product Description
- Milagen Inc Company Overview
  - Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Immunoassay - Breast Cancer - Product Status
    - Table Immunoassay - Breast Cancer - Product Description
- Morphotek Inc Company Overview
  - Morphotek Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Morphotek Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Assays - Folate Receptor Alpha (FRA) - Product Status
    - Table Companion Diagnostic Assays - Folate Receptor Alpha (FRA) - Product Description
- MW Diagnostics Ltd Company Overview
  - MW Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table MW Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(MW Diagnostics Ltd)
    - Table Diagnostic Test - Breast Cancer - Product Description(MW Diagnostics Ltd)
- Nanostics Inc Company Overview
  - Nanostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Nanostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table ClarityDX Breast - Product Status
    - Table ClarityDX Breast - Product Description
- NanoString Technologies Inc Company Overview
  - NanoString Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table NanoString Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Test - Enzalutamide - Product Status
    - Table Companion Diagnostic Test - Enzalutamide - Product Description
    - Table NanoString Technologies Inc - Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Test - Enzalutamide - Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR(+) Triple Negative Breast Cancer
- New York University Company Overview
  - New York University Pipeline Products & Ongoing Clinical Trials Overview
    - Table New York University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Prognostic Test - Breast Cancer - Product Status(New York University)
    - Table Prognostic Test - Breast Cancer - Product Description(New York University)
- Newcastle University Company Overview
  - Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
    - Table SmartHEALTH POC System - Breast Cancer - Product Status
    - Table SmartHEALTH POC System - Breast Cancer - Product Description
- Nonagen Bioscience Corp Company Overview
  - Nonagen Bioscience Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Nonagen Bioscience Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status(Nonagen Bioscience Corp)
    - Table Diagnostic Assay - Breast Cancer - Product Description(Nonagen Bioscience Corp)
- Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
  - Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Tissue Biopsy Test - Product Status
    - Table Breast Tissue Biopsy Test - Product Description
    - Table NBT Diagnostic Test - Breast Cancer - Product Status
    - Table NBT Diagnostic Test - Breast Cancer - Product Description
- Nuclea Biotechnologies Inc. (Inactive) Company Overview
  - Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Decision Dx - Breast Cancer - Product Status
    - Table Decision Dx - Breast Cancer - Product Description
    - Table Prognostic Assay - Breast Cancer - Product Status
    - Table Prognostic Assay - Breast Cancer - Product Description
    - Table USP2a Diagnostic Assay - Breast Cancer - Product Status
    - Table USP2a Diagnostic Assay - Breast Cancer - Product Description
- Nuvera Biosciences Inc Company Overview
  - Nuvera Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Nuvera Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Aromatase Inhibitor Biomarker - Companion Diagnostic Test - Product Status
    - Table Aromatase Inhibitor Biomarker - Companion Diagnostic Test - Product Description
    - Table Breast Cancer Chemotherapy Sensitivity - Product Status
    - Table Breast Cancer Chemotherapy Sensitivity - Product Description
    - Table Therapy-Resistance Diagnostic Test - Product Status
    - Table Therapy-Resistance Diagnostic Test - Product Description
- Olink Proteomics AB Company Overview
  - Olink Proteomics AB Pipeline Products & Ongoing Clinical Trials Overview
    - Table Olink Proteomics AB Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Assay - Aromatase - Product Status
    - Table Companion Diagnostic Assay - Aromatase - Product Description
    - Table Companion Diagnostic Assay - Trastuzumab - Product Status
    - Table Companion Diagnostic Assay - Trastuzumab - Product Description
    - Table HER2-pEGFR Kit - Product Status
    - Table HER2-pEGFR Kit - Product Description
- Olympia Diagnostics Inc Company Overview
  - Olympia Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Olympia Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Prognostic Test - Breast Cancer - Product Status(Olympia Diagnostics Inc)
    - Table Prognostic Test - Breast Cancer - Product Description(Olympia Diagnostics Inc)
- Oncimmune (USA) LLC Company Overview
  - Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table EarlyCDT - Breast Cancer - Product Status
    - Table EarlyCDT - Breast Cancer - Product Description
- OncoCyte Corp Company Overview
  - OncoCyte Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table OncoCyte Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Confirmatory BI RADS 3-4 Assay - Product Status
    - Table Breast Confirmatory BI RADS 3-4 Assay - Product Description
    - Table Dense Breast Tissue Confirmatory Test - Breast Cancer - Product Status
    - Table Dense Breast Tissue Confirmatory Test - Breast Cancer - Product Description
- Onconome, Inc. (Inactive) Company Overview
  - Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast Cancer Diagnostic Assay - Product Status
    - Table Breast Cancer Diagnostic Assay - Product Description
    - Table Breast Cancer Prognostic Assay - Product Status
    - Table Breast Cancer Prognostic Assay - Product Description
- OncoStem Diagnostics Pvt. Ltd Company Overview
  - OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table CanAssist - Triple-Negative Breast Cancer - Product Status
    - Table CanAssist - Triple-Negative Breast Cancer - Product Description
- OncoVista Innovative Therapies Inc Company Overview
  - OncoVista Innovative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table OncoVista Innovative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table OVI-117 Biomarker - Breast Cancer - Product Status
    - Table OVI-117 Biomarker - Breast Cancer - Product Description
- Oregon Health & Science University Company Overview
  - Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Based Prognostic Test - Breast Cancer - Product Status
    - Table Biomarker Based Prognostic Test - Breast Cancer - Product Description
- OSLER Diagnostics Ltd Company Overview
  - OSLER Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table OSLER Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Based Test - Breast Cancer - Product Status
    - Table Biomarker Based Test - Breast Cancer - Product Description
- OTraces Inc Company Overview
  - OTraces Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table OTraces Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table BC Sera Dx - Product Status
    - Table BC Sera Dx - Product Description
- Peri Rx Inc Company Overview
  - Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Saliva Test - Breast Cancer - Product Status
    - Table Saliva Test - Breast Cancer - Product Description
- Power3 Medical Products, Inc. Company Overview
  - Power3 Medical Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Power3 Medical Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table BC-SeraPro - Product Status
    - Table BC-SeraPro - Product Description
- Precision Biologics Inc Company Overview
  - Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status
    - Table Diagnostic Assay - Breast Cancer - Product Description
- Prelude Corp Company Overview
  - Prelude Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Prelude Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table DCISionRT - Stage 1 Breast Cancer - Product Status
    - Table DCISionRT - Stage 1 Breast Cancer - Product Description
- PreMD Inc (Inactive) Company Overview
  - PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table PreMD Diagnostic Test - Breast Cancer - Product Status
    - Table PreMD Diagnostic Test - Breast Cancer - Product Description
- Princeton University Company Overview
  - Princeton University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Princeton University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Prognostic Biomarker Test - Bone Metastasis - Product Status
    - Table Prognostic Biomarker Test - Bone Metastasis - Product Description
- Proplex Technologies Llc Company Overview
  - Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
    - Table GASP-1 IHC Assay - Product Status
    - Table GASP-1 IHC Assay - Product Description
- Protagen AG Company Overview
  - Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
    - Table Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status(Protagen AG)
    - Table Diagnostic Assay - Breast Cancer - Product Description(Protagen AG)
- Proteome Sciences Plc Company Overview
  - Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Panel - Breast Cancer - Product Status(Proteome Sciences Plc)
    - Table Biomarker Panel - Breast Cancer - Product Description(Proteome Sciences Plc)
- Proteomika (Inactive) Company Overview
  - Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Proteomika Biomarker Test - Breast Cancer - Product Status
    - Table Proteomika Biomarker Test - Breast Cancer - Product Description
- Purdue University Company Overview
  - Purdue University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(Purdue University)
    - Table Diagnostic Test - Breast Cancer - Product Description(Purdue University)
- Rna Diagnostics Inc Company Overview
  - Rna Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Rna Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table RNA Disruption Assay - Breast Cancer - Product Status
    - Table RNA Disruption Assay - Breast Cancer - Product Description
    - Table Rna Diagnostics Inc - Ongoing Clinical Trials Overview
    - Table RNA Disruption Assay - Breast Cancer - Breast Cancer Response Evaluation for Individualized Therapy: BREVITY
- Roche Diagnostics Corp Company Overview
  - -Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table HER2 Low CDx Test - Product Status
    - Table HER2 Low CDx Test - Product Description
- Roche Diagnostics International Ltd Company Overview
  - Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Bevacizumab Companion Diagnostic Assay - Product Status
    - Table Bevacizumab Companion Diagnostic Assay - Product Description
    - Table Companion Diagnostic Assay - Triple-Negative Breast Cancer - Product Status
    - Table Companion Diagnostic Assay - Triple-Negative Breast Cancer - Product Description
    - Table Diagnostic Test - Breast Cancer - Product Status(Roche Diagnostics International Ltd)
    - Table Diagnostic Test - Breast Cancer - Product Description(Roche Diagnostics International Ltd)
    - Table HER2 (Human Epidermal Growth Factor Receptor 2) Expression/ Gene Amplification CDx Test - Pertuzumab - Product Status
    - Table HER2 (Human Epidermal Growth Factor Receptor 2) Expression/ Gene Amplification CDx Test - Pertuzumab - Product Description
    - Table HER2 Expression/ Gene Amplification T-DM1 Diagnostic Test - Product Status
    - Table HER2 Expression/ Gene Amplification T-DM1 Diagnostic Test - Product Description
    - Table PI3 Kinase Inhibitor - Taselisib Companion Diagnostic Assay - Product Status
    - Table PI3 Kinase Inhibitor - Taselisib Companion Diagnostic Assay - Product Description
- Rosetta Genomics Ltd Company Overview
  - Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Prelude DCIS - Breast Cancer - Product Status
    - Table Prelude DCIS - Breast Cancer - Product Description
- RWTH Aachen University Company Overview
  - RWTH Aachen University Pipeline Products & Ongoing Clinical Trials Overview
    - Table RWTH Aachen University Pipeline Products & Ongoing Clinical Trials Overview
    - Table Liquid Biopsy Test - Breast Cancer - Product Status
    - Table Liquid Biopsy Test - Breast Cancer - Product Description
- Savicell Diagnostic Ltd. Company Overview
  - Savicell Diagnostic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Savicell Diagnostic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Savicell Well-Shield - Breast Cancer - Product Status
    - Table Savicell Well-Shield - Breast Cancer - Product Description
- Selventa Inc Company Overview
  - Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Panel - Breast Cancer - Product Status
    - Table Biomarker Panel - Breast Cancer - Product Description
- Sengenics Corp Pte Ltd Company Overview
  - Sengenics Corp Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Sengenics Corp Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Sengenics Diagnostic Test - Breast Cancer - Product Status
    - Table Sengenics Diagnostic Test - Breast Cancer - Product Description
- Siemens Healthineers AG Company Overview
  - Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
    - Table Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
    - Table Companion Diagnostic Test - Palbociclib - Product Status
    - Table Companion Diagnostic Test - Palbociclib - Product Description
- SomaLogic Inc Company Overview
  - SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table SomaSignal Test - Breast Cancer - Product Status
    - Table SomaSignal Test - Breast Cancer - Product Description
- Soricimed Biopharma Inc Company Overview
  - Soricimed Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Soricimed Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic SOR-D01 Assay - Breast Cancer - Product Status
    - Table Diagnostic SOR-D01 Assay - Breast Cancer - Product Description
    - Table Diagnostic SOR-D02 Assay - Breast Cancer - Product Status
    - Table Diagnostic SOR-D02 Assay - Breast Cancer - Product Description
- Syantra Inc Company Overview
  - Syantra Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Syantra Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Breast CancerScout - Product Status
    - Table Breast CancerScout - Product Description
- Target Discovery Inc Company Overview
  - Target Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Target Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Isonostic Assay - Breast Cancer - Product Status
    - Table Isonostic Assay - Breast Cancer - Product Description
- Taxor Diagnostics, LLC Company Overview
  - Taxor Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Taxor Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(Taxor Diagnostics, LLC)
    - Table Diagnostic Test - Breast Cancer - Product Description(Taxor Diagnostics, LLC)
- TechnoGenesys, Inc. Company Overview
  - TechnoGenesys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table TechnoGenesys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Akt Phosphorylation Test - Product Status
    - Table Akt Phosphorylation Test - Product Description
- The University of Nottingham Company Overview
  - The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
    - Table The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
    - Table Early Blood Test - Breast Cancer - Product Status
    - Table Early Blood Test - Breast Cancer - Product Description
- Treos Bio Inc Company Overview
  - Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table PolyPEPI 916 CDx - Product Status
    - Table PolyPEPI 916 CDx - Product Description
- Trinity College Dublin Company Overview
  - Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
    - Table Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
    - Table Peptide Biomarker - Breast Cancer - Product Status
    - Table Peptide Biomarker - Breast Cancer - Product Description
- Universal Diagnostics SL Company Overview
  - Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview
    - Table Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview
    - Table Blood-Based Diagnostic Test - Breast Cancer - Product Status
    - Table Blood-Based Diagnostic Test - Breast Cancer - Product Description
- University of Alberta Company Overview
  - University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status
    - Table Diagnostic Assay - Breast Cancer - Product Description
- University of Bergen Company Overview
  - University of Bergen Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Bergen Pipeline Products & Ongoing Clinical Trials Overview
    - Table Prognostic Marker Test - Breast Cancer - Product Status
    - Table Prognostic Marker Test - Breast Cancer - Product Description
- University of Bonn Company Overview
  - University of Bonn Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Bonn Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Breast Cancer - Product Status(University of Bonn)
    - Table Diagnostic Test - Breast Cancer - Product Description(University of Bonn)
    - Table Prognostic Test - Breast Cancer - Product Status
    - Table Prognostic Test - Breast Cancer - Product Description
- University of California San Diego Company Overview
  - University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
    - Table sdAb Diagnostic Reagent - Product Status
    - Table sdAb Diagnostic Reagent - Product Description
- University of Colorado Company Overview
  - University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
    - Table MicroRNA Assay - Breast Cancer - Product Status
    - Table MicroRNA Assay - Breast Cancer - Product Description
    - Table Multiplex ELISA Assay - Breast Cancer - Product Status
    - Table Multiplex ELISA Assay - Breast Cancer - Product Description
- University of Hong Kong Company Overview
  - University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Tool - Breast Cancer - Product Status
    - Table Diagnostic Tool - Breast Cancer - Product Description
- University of Kansas Company Overview
  - University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Ductal Carcinoma - Product Status
    - Table Diagnostic Assay - Ductal Carcinoma - Product Description
- University of Lyon Company Overview
  - University of Lyon Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Lyon Pipeline Products & Ongoing Clinical Trials Overview
    - Table Metastatic Relapse Biomarker - Breast Cancer - Product Status
    - Table Metastatic Relapse Biomarker - Breast Cancer - Product Description
- University of Minnesota Company Overview
  - University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Test - Aggressive Breast Cancer - Product Status
    - Table Diagnostic Test - Aggressive Breast Cancer - Product Description
- University of Missouri Company Overview
  - University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
    - Table P-Scan Device - Product Status
    - Table P-Scan Device - Product Description
- University of Nebraska Company Overview
  - University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker-Based Assay - Breast Cancer - Product Status
    - Table Biomarker-Based Assay - Breast Cancer - Product Description
- University of Oxford Company Overview
  - University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
    - Table Metal Test - Breast Cancer - Product Status
    - Table Metal Test - Breast Cancer - Product Description
- University of Pittsburgh Company Overview
  - University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Test - Breast Cancer - Product Status
    - Table Biomarker Test - Breast Cancer - Product Description
- University of South Carolina Company Overview
  - University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
    - Table CCL24 Based Diagnostic Test - Breast Cancer - Product Status
    - Table CCL24 Based Diagnostic Test - Breast Cancer - Product Description
- University of South Florida Company Overview
  - University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
    - Table Tumorigenic Marker - Breast Cancer - Product Status
    - Table Tumorigenic Marker - Breast Cancer - Product Description
- University of Toledo Company Overview
  - University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
    - Table Nitric Oxide Test - Breast Cancer - Product Status
    - Table Nitric Oxide Test - Breast Cancer - Product Description
- University of Turku Company Overview
  - University of Turku Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Turku Pipeline Products & Ongoing Clinical Trials Overview
    - Table Lectin-Nanoparticle Biomarker - Breast Cancer - Product Status
    - Table Lectin-Nanoparticle Biomarker - Breast Cancer - Product Description
- University of Wisconsin Madison Company Overview
  - University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
    - Table University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
    - Table REST Diagnostic Test - Breast Cancer - Product Status
    - Table REST Diagnostic Test - Breast Cancer - Product Description
- US Biomarkers Inc Company Overview
  - US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Blood-Based Biomarker - Breast Cancer - Product Status
    - Table Blood-Based Biomarker - Breast Cancer - Product Description
- Vala Sciences Inc Company Overview
  - Vala Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Vala Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Multiplex Imaging - Breast Cancer Device - Product Status
    - Table Multiplex Imaging - Breast Cancer Device - Product Description
- Vermillion Inc Company Overview
  - Vermillion Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Vermillion Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Biomarker Assay - Breast Cancer - Product Status
    - Table Biomarker Assay - Breast Cancer - Product Description
    - Table MammoCheck - Product Status
    - Table MammoCheck - Product Description
- Viomics Inc. Company Overview
  - Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
    - Table Viomics Diagnostic Assay - Breast Cancer - Product Status
    - Table Viomics Diagnostic Assay - Breast Cancer - Product Description
- Vitruvian Biomedical Inc Company Overview
  - Vitruvian Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Vitruvian Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Diagnostic Assay - Breast Cancer - Product Status(Vitruvian Biomedical Inc)
    - Table Diagnostic Assay - Breast Cancer - Product Description(Vitruvian Biomedical Inc)
- VolitionRX Ltd Company Overview
  - VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Status
    - Table NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Description
    - Table NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Status
    - Table NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Description
- Washington University in St Louis Company Overview
  - Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
    - Table Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
    - Table Predictive Biomarker - Breast Cancer - Product Status
    - Table Predictive Biomarker - Breast Cancer - Product Description
- XEPTAGEN SpA Company Overview
  - XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
    - Table XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
    - Table CA15.3 - IgM Kit - Product Status
    - Table CA15.3 - IgM Kit - Product Description
    - Table CEA - IgM Kit - Breast Cancer - Product Status
    - Table CEA - IgM Kit - Breast Cancer - Product Description
- Zetiq Technologies Ltd Company Overview
  - Zetiq Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Zetiq Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table CellDetect - Breast Cancer - Product Status
    - Table CellDetect - Breast Cancer - Product Description
Breast Cancer- Recent Developments
- Oct 28, 2020: Magnolia Health urges breast cancer screenings after delays due to COVID-19 pandemic
- Oct 27, 2020: Anixa Biosciences to host conference call to provide update on programs
- Oct 21, 2020: Henry Schein supports the global fight against cancer through its Practice Pink Program
- Oct 15, 2020: United Health Foundation pledges $2.5 Million to support breast cancer screenings for Michigan residents
- Oct 08, 2020: ConcertAI creates covid-19 oncology resources to improve real-world evidence-based cancer care and research during and after pandemic
- Sep 11, 2020: Veracyte announces initiation of consensus study exploring medical utility of multiple breast cancer genomic tests
- Sep 07, 2020: Markers may predict patient response to immune therapy of cancer
- Sep 01, 2020: Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
- Aug 14, 2020: New $5.1 million grant for Einstein-developed tests for breast cancer metastasis
- Aug 04, 2020: Financial Results of Astellas for the first three months of FY2020
- Jul 31, 2020: Physiomics awarded contract by Astellas Pharma Inc
- Jul 23, 2020: Astellas partners with LabCentral to help emerging Biotechs accelerate preclinical scientific research
- Jul 10, 2020: Anixa Biosciences' CAR-T cancer therapy receives intention to grant notice from the European Patent Office
- Jun 25, 2020: SEC charges Novartis with FCPA violations
- Jun 10, 2020: Nanopatterned 'lab-on-a-chip' noninvasively detects early and advanced breast cancer
- Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fasttrack construction of smart biotech facilities
- Jun 02, 2020: Pfizer establishes new program to support continued biotechnology innovation
- May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology
- May 27, 2020: At-home screening for ovarian, breast cancers is effective
- May 18, 2020: QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting
- May 04, 2020: StageZero Life Sciences announces enhanced relationship with Phleb- Finders
- Apr 29, 2020: Cancer testing and diagnosis suffers sharp downturn, finds Diaceutics
- Apr 15, 2020: High-res imaging with elastography may accurately detect breast cancer in surgical margins
- Apr 15, 2020: High-resolution imaging coupled with elastography may accurately detect breast cancer in surgical margins
- Apr 03, 2020: StageZero Life Sciences announces publication of abstract at American society of clinical oncology
- Apr 03, 2020: NeoGenomics integrates HALO from Indica Labs
- Apr 01, 2020: Genetic Technologies announces market update on sales, early test results and launch of consumer initiated testing
- Mar 12, 2020: Lineage Cell Therapeutics reports fourth quarter and full year 2019 financial results and provides business update
- Mar 06, 2020: PreludeDx announces new response type Biosignature data at the 37th Annual Miami Breast Cancer Conference
- Mar 04, 2020: Breast MRI associated with a significantly higher rate of invasive cancer detection than digital breast tomosynthesis
- Mar 04, 2020: The potential benefits of AI for breast cancer detection
- Feb 28, 2020: Leica Microsystems announces new market representation for Mid- Atlantic medical market
- Feb 27, 2020: James Quincey elected to Pfizer's board of directors
- Feb 26, 2020: MDxHealth reports financial year 2019 results and provides outlook for 2020
- Feb 26, 2020: bioMerieux - 2019 financial results
- Feb 25, 2020: TCS digitally transforms Qiagen's global research platform to improve user experience with new digital capabilities
- Feb 24, 2020: New tech takes radiation out of cancer screening
- Feb 19, 2020: Duke University and Leica Microsystems establish Center of Excellence in Microscopy
- Feb 14, 2020: Pfizer: Appointment of Mr. Samir Kazi as an executive director
- Feb 14, 2020: Pfizer: Resignation of Mr. Vivek Dhariwal
- Feb 11, 2020: Celerion expands clinical research to Nebraska Innovation Campus
- Feb 06, 2020: BD announces results for 2020 first fiscal quarter; lowers fiscal 2020 guidance
- Feb 06, 2020: UT Southwestern nearly doubles lifespan of mice with brain cancer
- Feb 05, 2020: Astellas announces management structure
- Feb 05, 2020: GSK delivers 2019 sales of £33.8 billion +10% AER, +8% CER (Pro-forma +4% CER)
- Feb 05, 2020: UMass Amherst study aims to develop new test for BRCA-positive lactating moms
- Feb 04, 2020: Building a better breast
- Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth - outlook confirmed
- Jan 31, 2020: Astellas will renew its corporate website's Innovation Section
- Jan 30, 2020: Quest Diagnostics reports record fourth quarter and full year 2019 revenues and earnings; provides guidance for full year 2020; increases dividend 5.7% to $0.56 per quarter
- Jan 30, 2020: Oncocyte announces relocation of its headquarters to Orange County, California
- Jan 30, 2020: OGT launches breakthrough NGS panel for constitutional cytogenetics
- Jan 29, 2020: Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019
- Jan 28, 2020: Pfizer reports fourth-quarter and full-year 2019 results
- Jan 27, 2020: CMS expands coverage of next generation sequencing as a diagnostic tool for patients with breast and ovarian cancer
- Jan 22, 2020: Novartis establishes its new legal entity in Vietnam
- Jan 22, 2020: GlaxoSmithKline signs agreement to invest £5M in Egypt
- Jan 21, 2020: Magnetised molecules used to monitor breast cancer
- Jan 21, 2020: Biomark's scientific advisor named Dean of the Schulich School of Medicine and Dentistry
- Jan 17, 2020: Frequency, mutational patterns, and genomic profile of hypermutated Breast Cancer
- Jan 14, 2020: Ipsen appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief Medical Officer
- Jan 14, 2020: Solos Endoscopy will look to become a women's healthcare focused company
- Jan 13, 2020: Foundation Medicine appoints Ritesh Khullar as Chief Commercial Officer
- Jan 13, 2020: HTG Molecular Diagnostics announces preliminary 2019 unaudited financial results
- Jan 08, 2020: Deborah Waterhouse, CEO of ViiV Healthcare, to join GSK Corporate Executive Team (CET)
- Jan 07, 2020: Clovis Oncology announces debt refinancing transaction
- Jan 07, 2020: Clovis Oncology announces product revenues for the fourth quarter and full year 2019
- Jan 07, 2020: Google AI platform aids oncologists in breast cancer screenings
- Jan 06, 2020: Atossa Genetics announces Corporate name change to Atossa Therapeutics
- Jan 06, 2020: Jack Westfall, MD, MPH, Named Director of Robert Graham Center
- Jan 02, 2020: Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020
- Jan 02, 2020: Lineage Cell Therapeutics conducts sale of shares in oncocyte
- Jan 01, 2020: Artificial intelligence could help breast screening save more lives
- Dec 31, 2019: Biomark announces appointment of Scientific and Medical Advisors, grant of stock options and changes in Board Of Directors
- Dec 24, 2019: Ad-hoc announcement pursuant to article 17 market abuse regulation
- Dec 19, 2019: Biomark Diagnostics reviews 2019 and outlines plans for 2020
- Dec 18, 2019: Ipsen announces departure of David Meek as chief executive officer
- Dec 18, 2019: Pfizer and Mylan announce two future Viatris board members
- Dec 17, 2019: Sengenics, a leading commercial stage precision medicine focused company, which enables pharma companies to identify drug responders, to present at Biotech Showcase 2020
- Dec 17, 2019: AI improves breast cancer risk prediction
- Dec 16, 2019: Pfizer declares first-quarter 2020 dividend and announces upcoming investor day to highlight strength of innovative R&D pipeline
- Dec 13, 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type
- Dec 12, 2019: Blood test can quickly match advanced breast cancer patients to targeted treatment
- Dec 11, 2019: Celcuity presents results at the 2019 San Antonio Breast Cancer Symposium evaluating a sub-group of PIK3CA WT breast cancer patients who have hyperactive signaling tumors responsive to PI3K inhibitors
- Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
- Dec 06, 2019: SWOG: New markers for triple negative breast cancer
- Dec 05, 2019: Epic Sciences to present new data showing feasibility of its liquid biopsy test in breast cancer
- Dec 05, 2019: Novartis expects to sustain long-term growth with a robust pipeline of 25+ potential blockbusters highlighted at R&D Day
- Dec 03, 2019: Biocept's Liquid Biopsy CTC testing for breast cancer to be featured in Ppster presentation at the 2019 San Antonio Breast Cancer Symposium
- Dec 03, 2019: Groundbreaking study seeks volunteers to help modernize breast cancer screening
- Dec 02, 2019: Anixa Biosciences announces presentation at the 2019 San Antonio Breast Cancer Symposium
- Dec 02, 2019: Developing a new AI breast cancer diagnostic tool
- Nov 28, 2019: MedMira reports 2019 fourth quarter and year end financial results
- Nov 28, 2019: Sengenics ramps Up for further growth, announces expansion of its sales and business development teams in the USA, Europe and Asia
- Nov 27, 2019: The Center for Diagnostic Imaging discusses how breast MRIs can help prevent breast cancer
- Nov 27, 2019: Sanford Health: Artificial intelligence may help spot cancer in image scans
- Nov 26, 2019: Biennial mammography screening yields more advanced-stage cancers
- Nov 25, 2019: Sekisui Diagnostics opens $1.9 million Bioprocess Innovation Centre
- Nov 20, 2019: Oncotype DX Breast Recurrence Score reveals sex-related differences in mortality prediction in patients with early-stage ER-positive breast cancer
- Nov 15, 2019: QIAGEN receives several conditional, non-binding indications of interest, enters into discussions to explore potential strategic alternatives
- Nov 15, 2019: StageZero Life Sciences announces Q3 2019 progress update
- Nov 13, 2019: Imagion Biosystems patent issued in India
- Nov 13, 2019: Biocept reports third quarter 2019 financial results
- Nov 13, 2019: Atossa Genetics announces third quarter 2019 financial results and provides company update
- Nov 12, 2019: Lineage Cell Therapeutics reports third quarter 2019 financial results and provides business update
- Nov 12, 2019: VolitionRx announces third quarter 2019 financial results and business update
- Nov 12, 2019: Vermillion reports third quarter 2019 financial results
- Nov 12, 2019: Mylan and Pfizer announce Viatris as the new company name in the planned Mylan-Upjohn combination
- Nov 12, 2019: OGT continues move into molecular diagnostics markets
- Nov 11, 2019: MDxHealth provides Q3-2019 business update
- Nov 11, 2019: NIH RO1 grant to help improve ultrasound tomography for breast cancer detection
- Nov 08, 2019: Dana-Farber Cancer Institute earns "LGBTQ Health Care Equality Top Performer" Designation in HRC Foundation's Healthcare Equality Index
- Nov 07, 2019: Anixa Biosciences announces presentation at Cell Symposia: Hallmarks of Cancer
- Nov 07, 2019: Clovis Oncology announces third quarter 2019 operating results
- Nov 05, 2019: Ipsen appoints Howard Mayer, M.D. as Executive Vice President and head of Research and Development
- Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance
- Nov 05, 2019: Montefiore Medicine names Philip O. Ozuah, MD, PhD, as CEO
- Nov 05, 2019: Quest Diagnostics Earns Gold Status in American Heart Association's 2019 Workplace Health Achievement Index
Appendix
- Methodology
  - Table Glossary
- About GlobalData
- Contact Us
- Disclaimer